Last reviewed · How we verify

NCT04500509

Diclofenac Potassium With or Without Vaginal Dinoprostone Prior to Hysterosalpingography

Completed NA Last updated 19 January 2022
What this trial tests

NA trial testing diclofenac potassium + dinoprostone in Infertility, Female in 200 participants. Completed in 30 October 2021.

Timeline
1 September 2020
Primary endpoint
1 August 2021
30 October 2021

Quick facts

Lead sponsorAswan University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment200
Start date1 September 2020
Primary completion1 August 2021
Estimated completion30 October 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Aswan University Hospital

Who can join

Adults 18 to 45, female only, with Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to determine the efficacy of oral diclofenac potassium with or without vaginal dinoprostone prior to hysterosalpingography in primarily infertile patients on the pain scores during HSG.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility, Female

Currently open trials in the same condition.

Other Aswan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04500509.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing